Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-28 @ 2:58 AM
Study NCT ID:
NCT05300035
Status:
RECRUITING
Last Update Posted:
2024-12-27
First Post:
2022-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Sponsor:
ANRS, Emerging Infectious Diseases
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
ANRS 176 RHIVIERA-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None